USPTO serial 79292001
Serial No. 79292001
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 30, 2021
- Examiner
- HARMON, RAYMOND E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with Serial No. 79292001?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Molly Buck Richard
Molly Buck Richard Richard Law Group5910 N. Central ExpresswaySuite 325Dallas, TX 75206Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Surgical apparatus and instruments and medical apparatus and instruments for use in surgery; surgical devices for use in drug delivery, namely, syringes, hypodermic needles, catheters and cannulas for use in drug delivery; external and implantable medical devices, namely, prosthetic devices in the nature of gastrointestinal implants, diagnostic medical devices for diagnosing gastrointestinal disorders and diseases, and devices to control the fluid in and out of stoma ; Medical instruments, devices and apparatus for use in diagnostic testing of the gastrointestinal tract; medical devices for use in treating or diagnosing functional gastrointestinal disorders; gastrointestinal implants composed of artificial materials; medical instruments for delivery and retrieval of gastrointestinal implants; medical apparatus, namely, systems for delivery and retrieval of gastrointestinal implants; surgical devices for use with patients with colorectal cancer and other gastrointestinal diseases; surgical implants comprised of artificial materials; surgical instruments and apparatus; medical instruments for interstitial thermotherapy of biological tissue; implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for the treatment of gastrointestinal disorders and diseases; prosthetic gastrointestinal implants and implants for use in urostomies; medical implants comprised of artificial materials; intravascular implants made from artificial materials; medical devices for placing and securing catheters; catheters; medical devices for use in treating or diagnosing rectal cancer, colon cancer, polyps, fistulas, high output ileostomies, high output fistulas; medical devices to assist in trans-anal surgery; medical devices for intestinal re-feeding; medical devices for intestinal drug deployment; medical devices for intestinal content diversion; medical devices for use in treating or diagnosing gastrointestinal disease | ACTIVE | — |
| 042 | Design and development of medical and surgical devices, medical and surgical apparatus, external and implantable medical devices including prosthetic and diagnostic medical devices, and medical instruments; scientific and industrial research, design, testing, analysis and development of surgical and medical apparatus and instruments; design and development of non-downloadable software for facilitating interactions between patients and physicians via a clinical support platform, and design and development of non-downloadable software for analysing health data and metric for monitoring and evaluation patients; providing a platform-as-a-service (PaaS) featuring computer software platforms to enable patients and health care providers to interact remotely, health care providers to access and manage patient medical data, patients to receive information and advertising related to their health care, and patients and clinicians to purchase health care products, for digital health care purposes; medical research services and scientific laboratory services for acquiring, testing and screening data within the framework of continuous health monitoring; design and development of surgical devices for use in drug delivery, external and implantable medical devices including prosthetic and diagnostic medical devices, medical instruments, devices and apparatus device for use in diagnostic testing of the gastrointestinal tract, medical devices for use in treating or diagnosing functional gastrointestinal disorders, gastrointestinal implants composed of artificial materials, systems for delivery and retrieval of gastrointestinal implants, surgical devices for use with patients with colorectal cancer and other gastrointestinal diseases, surgical implants comprised of artificial materials, surgical instruments and apparatus, medical instruments for interstitial thermotherapy of biological tissue, implantable subcutaneous drug delivery devices, prosthetic implants, medical implants comprised of artificial materials, intravascular implants made from artificial materials, medical devices for placing and securing catheters, catheters, medical devices for use in treating or diagnosing rectal cancer, colon cancer, polyps, fistulas including high output fistulas, high output ileostomies, medical devices to assist in trans-anal surgery, medical devices for intestinal re-feeding, medical devices for intestinal drug deployment, medical devices for intestinal content diversion, and medical devices for use in treating or diagnosing gastrointestinal disease | ACTIVE | — |
| 044 | Medical services and surgical services, namely, gastrointestinal surgery, gynecological surgery, colorectal surgery and endoscopies of the gastrointestinal tract; Medical and surgical diagnostic testing, monitoring and reporting services; fitting of prosthetics; medical diagnostic testing, monitoring and reporting services in the fields of medicine related to the gastrointestinal tract; DNA screening for medical purposes, namely, medical DNA and genetic testing for the diagnosis of conditions of the gastrointestinal tract; medical diagnostic testing and reporting services for conditions of the gastrointestinal tract; medical services, namely, collection of human cell or tissue samples for the diagnosis of conditions of the gastrointestinal tract; remote patient monitoring services to assist medical professionals in providing medical diagnosis and treatment; medical services, namely, monitoring of losses of intestinal fluid from enterostomies; medical services, namely, monitoring of patient adherence to intestinal re-feeding; medical services, namely, intestinal drug delivery services; medical services, namely, intestinal probiotic delivery services; medical services, namely, intestinal microbiome monitoring | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by THE INSIDES COMPANY LIMITED
- Other trademarks owned by THE INSIDES COMPANY LIMITED
- Other trademarks owned by THE INSIDES COMPANY LIMITED
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 30, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 5, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 11, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 11, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 11, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 1, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 14, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 13, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 30, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 30, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 12, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 12, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 11, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 23, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 23, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 23, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 5, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 4, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 3, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 3, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 8, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 19, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 19, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 24, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 23, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 15, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 28, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 24, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 20, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |